PHARMACOKINETICS OF IVIG MAINTENANCE TREATMENT IN CIDP

被引：0
作者：
Fokkink, W-J R. [1 ,2 ]
Kuitwaard, K. [2 ]
Walgaard, C. [2 ]
van Rijs, W. [1 ,2 ]
Tio-Gillen, A. P. [1 ,2 ]
Huizinga, R. [1 ]
Birgit, Koch C. P. [3 ]
van Gelder, T. [3 ]
van Doom, P. A. [2 ]
Jacobs, B. C. [1 ,2 ]
机构：
[1] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands
[2] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands
[3] Erasmus MC, Univ Med Ctr Rotterdam, Hosp Pharm, Rotterdam, Netherlands
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2015年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [31] A serial analysis of conduction blocks after IVIG in a case of CIDP
    Nakamura, Y
    Sawada, M
    Sonoo, M
    Nakano, I
    MUSCLE & NERVE, 2005, 32 (03) : 388 - 388
  • [32] Response to IVIG in Patients with CIDP: The INSIGHTS Quality Improvement Registry
    Levine, Todd
    Katz, Jonathan
    Barohn, Richard
    Saperstein, David
    Wolfe, Gil
    Katzin, Lara
    Mozaffar, Tahseen
    Dimachkie, Mazen
    Badger, Gary
    Vaughn, Leslie
    Ritt, Elissa
    Greer, Michelle
    NEUROLOGY, 2016, 86
  • [33] Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP
    van Doorn, Pieter A.
    Kuitwaard, Krista
    Jacobs, Bart C.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : 38 - 40
  • [34] IVIG efficacy in CIDP patients is not associated with terminal complement inhibition
    Keller, Christian W.
    Quast, Isaak
    Dalakas, Marinos C.
    Luenemann, Jan D.
    JOURNAL OF NEUROIMMUNOLOGY, 2019, 330 : 23 - 27
  • [35] Practical application of subcutaneous immunoglobulin for maintenance treatment in CIDP: The PATH study
    Dimachkie, Mazen
    van Schaik, Ivo
    Bril, Vera
    van Geloven, Nan
    Hartung, Hans-Peter
    Lewis, Richard
    Sobue, Gen
    Lawo, John-Philip
    Mielke, Orell
    Durn, Billie
    Cornblath, David
    Merkies, Ingemar
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 357 - 358
  • [36] HOME BASED OUTCOMES DATA COLLECTION OF TREATMENT NAiVE CIDP WITH IVIG SHOWS DOSE MAY MATTER
    Allen, J. A.
    Ney, J.
    Brizuela, F.
    Schaefer, D.
    Cornblath, D. R.
    Lewis, R. A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 5 - 5
  • [37] SEARCH FOR A ROLE OF COMORBIDITIES IN VARIABILITY TO IVIG THERAPEUTIC RESPONSE IN CIDP
    Lucchesi, C.
    Schirinzi, E.
    Piazza, S.
    Buda, G.
    Tavoni, A.
    Siciliano, G.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S16 - S16
  • [38] Response to IVIG in Patients with CIDP: The INSIGHTS Quality Improvement Project
    Levine, Todd
    Katz, Jonathan
    Barohn, Richard
    Saperastein, David
    Wolfe, Gil
    Katzin, Lara
    Mozaffar, Tahseen
    Dimachkie, Mazen
    Badger, Gary
    Vaughan, Leslie
    Ritt, Elissa
    Greer, Michelle
    ANNALS OF NEUROLOGY, 2016, 80 : S163 - S163
  • [39] NK cells as surrogate marker for predicting efficacy of IVIg in CIDP
    Mausberg, A. K.
    Heininger, M. K.
    Zu Horste, G. Meyer
    Cordes, S.
    Kleinschnitz, C.
    Kieseier, B. C.
    Stettner, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 215 - 215
  • [40] IVIG treatment causes plasma hyperviscosity, circulating immune complexes and complement activation in ITP and CIDP patients
    Gyongyossy-Issa, MI
    Carter, CJ
    Racaza, A
    Devine, DV
    TRANSFUSION, 2004, 44 (09) : 133A - 133A
12345